0001462573-18-000003.txt : 20180827 0001462573-18-000003.hdr.sgml : 20180827 20180827114504 ACCESSION NUMBER: 0001462573-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180827 DATE AS OF CHANGE: 20180827 EFFECTIVENESS DATE: 20180827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AgeX Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821436829 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320068 FILM NUMBER: 181038441 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-521-3390 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 D 1 primary_doc.xml X0708 D LIVE 0001708599 AgeX Therapeutics, Inc. 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA CALIFORNIA 94501 510-521-3390 DELAWARE None None Corporation true 2017 Michael D. West 1010 Atlantic Avenue Suite 102 Alameda CA CALIFORNIA 94501 Executive Officer Director President and CEO Russell Skibsted 1010 Atlantic Avenue Suite 102 Alameda CA CALIFORNIA 94501 Executive Officer Chief Financial Officer Alfred D. Kingsley 150 E. 57th Street Suite 24E New York NY NEW YORK 10022 Executive Officer Director Executive Chairman Michael H. Mulroy 1010 Atlantic Avenue Suite 102 Alameda CA CALIFORNIA 94501 Director Not Applicable BioTime, Inc. 1010 Atlantic Avenue Suite 102 Alameda CA CALIFORNIA 94501 Promoter Parent company of Issuer John Mauldin 1010 Atlantic Avenue Suite 102 Alameda CA CALIFORNIA 94501 Director Biotechnology Decline to Disclose 06b false 2018-08-15 true true false Acquisition of assets from Escape Therapeutics, Inc., but not a business acquisition or combination. 0 Indefinite 200000 Indefinite Shares issued as partial consideration of purchase of assets. Additional shares may be issued if certain product development milestones are achieved. false 1 0 0 0 false AgeX Therapeutics, Inc. /s/ Russell Skibsted Russell Skibsted Chief Financial Officer 2018-08-24